Sinohealth Technology FY2025 net profit drops 15.5% to RMB94 million; revenue rises 3.8% to RMB419 million

Reuters03-27 22:01

Sinohealth Technology FY2025 net profit drops 15.5% to RMB94 million; revenue rises 3.8% to RMB419 million

Sinohealth published an annual results announcement, reporting revenue of RMB 419.1 million, up 3.8%.
Gross profit was RMB 249.1 million, up 6.8%, and gross profit margin was 59.4%, up 1.6 percentage points.
Operating profit rose 19% to RMB 91.6 million, while net profit fell 15.5% to RMB 94.5 million.
Commercial Solutions revenue increased 5.5% to RMB 273.2 million, while Data-driven Publications and Events revenue rose 0.4% to RMB 144.8 million.
Management cited increased AI-related R&D investment as contributing to short-term profit fluctuations, and said it elevated its positioning to a comprehensive AI technology services company based on healthcare-industry data assets and ecosystem resources.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Sinohealth Technology Holdings Ltd. published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20260327-12074301), on March 27, 2026, and is solely responsible for the information contained therein.

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2622827281?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-03-27 22:01","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2622827281","market":"nz","top_or_hot":-1,"title":"Sinohealth Technology FY2025 net profit drops 15.5% to RMB94 million; revenue rises 3.8% to RMB419 million","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\" xmlns:newsg2=\"http://iptc.org/std/nar/2006-10-01/\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><head><title>\n      Sinohealth Technology FY2025 net profit drops 15.5% to RMB94 million; revenue rises 3.8% to RMB419 million\n    </title></head><body><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<ul>\n<li>\n          Sinohealth published an annual results announcement, reporting revenue of RMB 419.1 million, up 3.8%.\n        </li>\n<li>\n          Gross profit was RMB 249.1 million, up 6.8%, and gross profit margin was 59.4%, up 1.6 percentage points.\n        </li>\n<li>\n          Operating profit rose 19% to RMB 91.6 million, while net profit fell 15.5% to RMB 94.5 million.\n        </li>\n<li>\n          Commercial Solutions revenue increased 5.5% to RMB 273.2 million, while Data-driven Publications and Events revenue rose 0.4% to RMB 144.8 million.\n        </li>\n<li>\n          Management cited increased AI-related R&amp;D investment as contributing to short-term profit fluctuations, and said it elevated its positioning to a comprehensive AI technology services company based on healthcare-industry data assets and ecosystem resources.\n        </li>\n</ul>\n<br/>\n<br/>\n</div><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n<i>Disclaimer: <span>This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Sinohealth Technology Holdings Ltd. published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20260327-12074301), on March 27, 2026, and is solely responsible for the information contained therein.</span></i>\n</p>\n</div></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Sinohealth Technology FY2025 net profit drops 15.5% to RMB94 million; revenue rises 3.8% to RMB419 million</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nSinohealth Technology FY2025 net profit drops 15.5% to RMB94 million; revenue rises 3.8% to RMB419 million\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2026-03-27 22:01</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\" xmlns:newsg2=\"http://iptc.org/std/nar/2006-10-01/\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><head><title>\n      Sinohealth Technology FY2025 net profit drops 15.5% to RMB94 million; revenue rises 3.8% to RMB419 million\n    </title></head><body><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<ul>\n<li>\n          Sinohealth published an annual results announcement, reporting revenue of RMB 419.1 million, up 3.8%.\n        </li>\n<li>\n          Gross profit was RMB 249.1 million, up 6.8%, and gross profit margin was 59.4%, up 1.6 percentage points.\n        </li>\n<li>\n          Operating profit rose 19% to RMB 91.6 million, while net profit fell 15.5% to RMB 94.5 million.\n        </li>\n<li>\n          Commercial Solutions revenue increased 5.5% to RMB 273.2 million, while Data-driven Publications and Events revenue rose 0.4% to RMB 144.8 million.\n        </li>\n<li>\n          Management cited increased AI-related R&amp;D investment as contributing to short-term profit fluctuations, and said it elevated its positioning to a comprehensive AI technology services company based on healthcare-industry data assets and ecosystem resources.\n        </li>\n</ul>\n<br/>\n<br/>\n</div><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n<i>Disclaimer: <span>This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Sinohealth Technology Holdings Ltd. published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20260327-12074301), on March 27, 2026, and is solely responsible for the information contained therein.</span></i>\n</p>\n</div></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4588","symbol_name":"碎股","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260327:nNDL2wQqr1:1","article_id":"2622827281","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2622827281","pubTimestamp":1774620110,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"Sinohealth published an annual results announcement, reporting revenue of RMB 419.1 million, up 3.8%.Gross profit was RMB 249.1 million, up 6.8%, and gross profit margin was 59.4%, up 1.6 percentage points.Operating profit rose 19% to RMB 91.6 million, while net profit fell 15.5% to RMB 94.5 million.Commercial Solutions revenue increased 5.5% to RMB 273.2 million, while Data-driven Publications and Events revenue rose 0.4% to RMB 144.8 million.Management cited increased AI-related R&D investment as contributing to short-term profit fluctuations, and said it elevated its positioning to a comprehensive AI technology services company based on healthcare-industry data assets and ecosystem resources.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal a","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4588":"碎股","LU2237443549.SGD":"Aberdeen Standard SICAV I - Global Dynamic Dividend A MIncA SGD-H","BK4585":"ETF&股票定投概念","LU0528227936.USD":"富达环球人口趋势基金A-ACC","LU2237443978.SGD":"Aberdeen Standard SICAV I - Global Dynamic Dividend A Acc SGD-H","LU1791710582.SGD":"Fidelity Global Demographics A-ACC-SGD (SGD/USD hedged)","GPC":"Genuine Parts Co","LU2237443622.USD":"Aberdeen Standard SICAV I - Global Dynamic Dividend A Acc USD","BK1189":"医疗保健技术","LU2237443382.USD":"Aberdeen Standard SICAV I - Global Dynamic Dividend A MIncA USD","LU1791710400.SGD":"Fidelity Global Demographics A-ACC-SGD","02361":"中康控股","BK4159":"经销商"},"translate_title":"SinoHealth Technology 2025财年净利润下降15.5%至人民币9400万元；收入增长3.8%至人民币4.19亿元","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02361":0.9,"GPC":0.9},"content_text":"Sinohealth Technology FY2025 net profit drops 15.5% to RMB94 million; revenue rises 3.8% to RMB419 million\n    \n\n\n          Sinohealth published an annual results announcement, reporting revenue of RMB 419.1 million, up 3.8%.\n        \n\n          Gross profit was RMB 249.1 million, up 6.8%, and gross profit margin was 59.4%, up 1.6 percentage points.\n        \n\n          Operating profit rose 19% to RMB 91.6 million, while net profit fell 15.5% to RMB 94.5 million.\n        \n\n          Commercial Solutions revenue increased 5.5% to RMB 273.2 million, while Data-driven Publications and Events revenue rose 0.4% to RMB 144.8 million.\n        \n\n          Management cited increased AI-related R&D investment as contributing to short-term profit fluctuations, and said it elevated its positioning to a comprehensive AI technology services company based on healthcare-industry data assets and ecosystem resources.\n        \n\n\n\n\n\nDisclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Sinohealth Technology Holdings Ltd. published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20260327-12074301), on March 27, 2026, and is solely responsible for the information contained therein.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":true,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.38.0","shortVersion":"4.38.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2622827281","isCrawlerRequest":true}